Rationalizing the treatment of hypertension.
Management of hypertension in this country is confounded by continual changes in recommended target blood pressure (BP) goals and a nonhomogeneous patient population who have a variety of demographic and clinical characteristics that influence treatment. This paper focuses on three major elements in managing hypertension: BP and the importance of reducing it to acceptably low levels; concomitant risk factors or cardiovascular and renal target involvement; and drug therapy that may confer prognostic advantages beyond those predicted by BP effects.
Weber
M A
MA
SUNY Health Science Center at Brooklyn, 11203, USA. michaelwebermd@cs.com
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012016:Reference Values
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers